메뉴 건너뛰기




Volumn 14, Issue 2, 2011, Pages 282-288

Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia

Author keywords

androgens; DHEA; dyspareunia; estrogens; intracrinology; Prasterone; vaginal atrophy

Indexed keywords

ANDROGEN; ESTROGEN; PLACEBO; PRASTERONE;

EID: 79952805859     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2010.535226     Document Type: Article
Times cited : (79)

References (51)
  • 1
    • 79952783821 scopus 로고    scopus 로고
    • Table1: Annual estimates of the population by sex and five-year age groups for the United States: April 1, to July 1, 2007, NC-EST2007-01. May 2008
    • Population Division US Census Bureau. Table1: Annual estimates of the population by sex and five-year age groups for the United States: April 1, 2000 to July 1, 2007. NC-EST2007-01. May 2008
    • (2000) Population Division US Census Bureau
  • 2
    • 0032845731 scopus 로고    scopus 로고
    • A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause
    • DOI 10.1016/S0029-7844(99)00359-2, PII S0029784499003592
    • Archer DF, Furst K, Tipping D, Dain MP, Vandepol C. A randomized comparison of continuous combined transdermal delivery of estradiol- norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group. Obstet Gynecol 1999; 94:498-503 (Pubitemid 29460929)
    • (1999) Obstetrics and Gynecology , vol.94 , Issue.4 , pp. 498-503
    • Archer, D.F.1    Furst, K.2    Tipping, D.3    Dain, M.-P.4    Vandepol, C.5
  • 3
  • 4
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women
    • Women's Health Initiative
    • Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288: 321-33
    • (2002) JAMA , vol.288 , pp. 321-333
  • 5
    • 0042018741 scopus 로고    scopus 로고
    • Breast cancer and hormone-replacement therapy in the Million Women Study
    • DOI 10.1016/S0140-6736(03)14065-2
    • Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-27 (Pubitemid 36999703)
    • (2003) Lancet , vol.362 , Issue.9382 , pp. 419-427
    • Beral, V.1
  • 7
    • 0030843969 scopus 로고    scopus 로고
    • Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59
    • (1997) Lancet , vol.350 , pp. 1047-1059
  • 9
    • 33845383231 scopus 로고    scopus 로고
    • Breast cancer risk in postmenopausal women using estrogen-only therapy
    • DOI 10.1097/01.AOG.0000241091.86268.6e, PII 0000625020061200000004
    • Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol 2006;108:1354-60 (Pubitemid 44901007)
    • (2006) Obstetrics and Gynecology , vol.108 , Issue.6 , pp. 1354-1360
    • Lyytinen, H.1    Pukkala, E.2    Ylikorkala, O.3
  • 12
    • 18144421167 scopus 로고    scopus 로고
    • Endometrial cancer and hormonereplacement therapy in the Million Women Study
    • Beral V, Bull D, Reeves G. Endometrial cancer and hormonereplacement therapy in the Million Women Study. Lancet 2005; 365:1543-51
    • (2005) Lancet , vol.365 , pp. 1543-1551
    • Beral, V.1    Bull, D.2    Reeves, G.3
  • 13
    • 0018891803 scopus 로고
    • Use of the progestogen challenge test to reduce the risk of endometrial cancer
    • Gambrell RD Jr, Massey FM, Castaneda TA, et al. Use of the progestogen challenge test to reduce the risk of endometrial cancer. Obstet Gynecol 1980;55:732-8 (Pubitemid 10068686)
    • (1980) Obstetrics and Gynecology , vol.55 , Issue.6 , pp. 732-738
    • Gambrell, R.D.1    Massey, F.M.2    Castaneda, T.A.3
  • 15
    • 77953643561 scopus 로고    scopus 로고
    • DHEA after menopause - sole source of sex steroids and potential sex steroid deficiency treatment
    • Labrie F. DHEA after menopause - sole source of sex steroids and potential sex steroid deficiency treatment. Menopause Management 2010;19:14-24
    • (2010) Menopause Management , vol.19 , pp. 14-24
    • Labrie, F.1
  • 16
  • 17
    • 34447623585 scopus 로고    scopus 로고
    • Drug Insight: Breast cancer prevention and tissue-targeted hormone replacement therapy
    • DOI 10.1038/ncpendmet0559, PII NCPENDMET0559
    • Labrie F. Drug Insight: Breast cancer prevention and tissuetargeted hormone replacement therapy. Nature Clinical Practice, Endocrinology & Metabolism 2007;3:584-93 (Pubitemid 47094559)
    • (2007) Nature Clinical Practice Endocrinology and Metabolism , vol.3 , Issue.8 , pp. 584-593
    • Labrie, F.1
  • 18
    • 73349115224 scopus 로고    scopus 로고
    • Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy
    • Labrie F, Archer D, Bouchard C, et al. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause 2009;16:907-22
    • (2009) Menopause , vol.16 , pp. 907-922
    • Labrie, F.1    Archer, D.2    Bouchard, C.3
  • 19
    • 72249101980 scopus 로고    scopus 로고
    • Effect on intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women
    • Labrie F, Archer D, Bouchard C, et al. Effect on intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause 2009;16:923-31
    • (2009) Menopause , vol.16 , pp. 923-931
    • Labrie, F.1    Archer, D.2    Bouchard, C.3
  • 20
    • 73349105263 scopus 로고    scopus 로고
    • Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration
    • Labrie F, Archer D, Bouchard C, et al. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause 2009;16:897-906
    • (2009) Menopause , vol.16 , pp. 897-906
    • Labrie, F.1    Archer, D.2    Bouchard, C.3
  • 21
    • 0014109952 scopus 로고
    • The maturation value
    • Meisels A. The maturation value. Acta Cytol 1967;11:249
    • (1967) Acta Cytol , vol.11 , pp. 249
    • Meisels, A.1
  • 22
    • 0027454291 scopus 로고
    • Industrial developments in automated cytology as submitted by their developers
    • Wied GL. Industrial developments in automated cytology as submitted by their developers. Anal Quant Cytol Histol 1993;15:358-70 (Pubitemid 23311389)
    • (1993) Analytical and Quantitative Cytology and Histology , vol.15 , Issue.5 , pp. 358-370
    • Wied, G.L.1
  • 23
    • 49449119071 scopus 로고    scopus 로고
    • Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women
    • Labrie F, Cusan L, Gomez JL, et al. Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. J Steroid Biochem Mol Biol 2008;111:178-94
    • (2008) J Steroid Biochem Mol Biol , vol.111 , pp. 178-194
    • Labrie, F.1    Cusan, L.2    Gomez, J.L.3
  • 24
    • 55349137697 scopus 로고    scopus 로고
    • Corrigendum to: Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women
    • Labrie F, Cusan L, Gomez JL, et al. Corrigendum to: Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. J Steroid Biochem Mol Biol 2008; 112:169
    • (2008) J Steroid Biochem Mol Biol , vol.112 , pp. 169
    • Labrie, F.1    Cusan, L.2    Gomez, J.L.3
  • 25
    • 0034658676 scopus 로고    scopus 로고
    • Diagnosis and treatment of atrophic vaginitis
    • Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000;61:3090-6 (Pubitemid 30347020)
    • (2000) American Family Physician , vol.61 , Issue.10 , pp. 3090-3096
    • Bachmann, G.A.1    Nevadunsky, N.S.2
  • 27
    • 37549023420 scopus 로고    scopus 로고
    • Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: A randomized controlled trial
    • Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: A randomized controlled trial. Obstet Gynecol 2008;111:67-76
    • (2008) Obstet Gynecol , vol.111 , pp. 67-76
    • Bachmann, G.1    Lobo, R.A.2    Gut, R.3    Nachtigall, L.4    Notelovitz, M.5
  • 28
    • 58149280795 scopus 로고    scopus 로고
    • Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet
    • Simon J, Nachtigall L, Gut R, et al. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet. Obstet Gynecol 2008;112:1053-60
    • (2008) Obstet Gynecol , vol.112 , pp. 1053-1060
    • Simon, J.1    Nachtigall, L.2    Gut, R.3
  • 29
    • 77951782692 scopus 로고    scopus 로고
    • Minimized estradiol absorption with ultra-low-dose 10 mg 17b-estradiol vaginal tablets
    • Eugster-Hausmann M, Waitzinger J, Lehnick D. Minimized estradiol absorption with ultra-low-dose 10 mg 17b-estradiol vaginal tablets. Climacteric 2010;13:219-27
    • (2010) Climacteric , vol.13 , pp. 219-227
    • Eugster-Hausmann, M.1    Waitzinger, J.2    Lehnick, D.3
  • 30
    • 77952270259 scopus 로고    scopus 로고
    • Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: Results from a pivotal phase 3 study
    • Ospemifene Study Group
    • Bachmann GA, Komi JO, Ospemifene Study Group. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: Results from a pivotal phase 3 study. Menopause 2010;17:480-6
    • (2010) Menopause , vol.17 , pp. 480-486
    • Bachmann, G.A.1    Komi, J.O.2
  • 31
    • 84987844143 scopus 로고    scopus 로고
    • Effect of toremifene and ospemifene, compared to acolbifene, on estrogensensitive parameters in rat and human uterine tissues
    • Labrie F, Martel C, Gauthier S, Pelletier G, Sancéau JY. Effect of toremifene and ospemifene, compared to acolbifene, on estrogensensitive parameters in rat and human uterine tissues. Horm Mol Biol Clin Invest 2010;1:139-46
    • (2010) Horm Mol Biol Clin Invest , vol.1 , pp. 139-146
    • Labrie, F.1    Martel, C.2    Gauthier, S.3    Pelletier, G.4    Sancéau, J.Y.5
  • 33
    • 69649108864 scopus 로고    scopus 로고
    • The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of the North American menopause society
    • NAMS
    • NAMS. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 Position Statement of the North American Menopause Society. Menopause 2007;14: 357-69
    • (2007) Menopause , vol.14 , pp. 357-369
  • 35
    • 0030842630 scopus 로고    scopus 로고
    • Postmenopausal vaginal atrophy and atrophic vaginitis
    • DOI 10.1097/00000441-199710000-00004
    • Pandit L, Ouslander JG. Postmenopausal vaginal atrophy and atrophic vaginitis. Am J Med Sci 1997;314:228-31 (Pubitemid 27435448)
    • (1997) American Journal of the Medical Sciences , vol.314 , Issue.4 , pp. 228-231
    • Pandit, L.1    Ouslander, J.G.2
  • 38
    • 59849125252 scopus 로고    scopus 로고
    • Comparable amounts of sex steroids are made outside the gonads in men and women: Strong lesson for hormone therapy of prostate and breast cancer
    • Labrie F, Cusan L, Gomez JL, et al. Comparable amounts of sex steroids are made outside the gonads in men and women: Strong lesson for hormone therapy of prostate and breast cancer. J Steroid Biochem Mol Biol 2009;113:52-6
    • (2009) J Steroid Biochem Mol Biol , vol.113 , pp. 52-56
    • Labrie, F.1    Cusan, L.2    Gomez, J.L.3
  • 39
    • 44649190349 scopus 로고    scopus 로고
    • Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA
    • Labrie F, Cusan L, Gomez JL, et al. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA. J Steroid Biochem Mol Biol 2008;110:1-9
    • (2008) J Steroid Biochem Mol Biol , vol.110 , pp. 1-9
    • Labrie, F.1    Cusan, L.2    Gomez, J.L.3
  • 40
    • 32044435429 scopus 로고    scopus 로고
    • Hormone therapy and coronary heart disease: The role of time since menopause and age at hormone initiation
    • DOI 10.1089/jwh.2006.15.35
    • Grodstein F, Manson JE, Stampfer MJ. Hormone therapy and coronary heart disease: The role of time since menopause and age at hormone initiation. JWomens Health (Larchmt) 2006;15:35-44 (Pubitemid 43192860)
    • (2006) Journal of Women's Health , vol.15 , Issue.1 , pp. 35-44
    • Grodstein, F.1    Manson, J.E.2    Stampfer, M.J.3
  • 42
    • 34547181486 scopus 로고    scopus 로고
    • The heart of the WHI study: Time for hormone therapy policies to be revised
    • DOI 10.1080/13697130701543783, PII 780574399
    • Pines A, Sturdee DW, MacLennan AH, et al. The heart of the WHI study: Time for hormone therapy policies to be revised. Climacteric 2007;10:267-9 (Pubitemid 47123948)
    • (2007) Climacteric , vol.10 , Issue.4 , pp. 267-269
    • Pines, A.1    Sturdee, D.W.2    MacLennan, A.H.3    Schneider, H.P.G.4    Burger, H.5    Fenton, A.6
  • 44
    • 78651408128 scopus 로고    scopus 로고
    • The menopause brain effect: Can hormone therapy help?
    • Ruttimann J. The menopause brain effect: Can hormone therapy help? Endocrine News 2008;15-16
    • (2008) Endocrine News , pp. 15-16
    • Ruttimann, J.1
  • 45
    • 84965028377 scopus 로고
    • Dehydroepiandrosterone and androsterone levels in human plasma. Effect of age and sex: Day-to-day and diurnal variations
    • Migeon CJ, Keller AR, Lawrence B, Shepart II TH. Dehydroepiandrosterone and androsterone levels in human plasma. Effect of age and sex: Day-to-day and diurnal variations. J Clin Endocrinol Metab 1957;17:1051-62
    • (1957) J Clin Endocrinol Metab , vol.17 , pp. 1051-1062
    • Migeon, C.J.1    Keller, A.R.2    Lawrence, B.3    Shepart II, T.H.4
  • 47
    • 77956639804 scopus 로고    scopus 로고
    • DHEA, important source of sex steroids in men and even more in women
    • In Martini L, Chrousos GP, Labrie F, Pacak K, Pfaff D, eds., New York: Elsevier
    • Labrie F. DHEA, important source of sex steroids in men and even more in women. In Martini L, Chrousos GP, Labrie F, Pacak K, Pfaff D, eds. Neuroendocrinology, The Normal Neuroendocrine System, Progress in Brain Research. New York: Elsevier, 2010:97-148
    • (2010) Neuroendocrinology, The Normal Neuroendocrine System, Progress in Brain Research , pp. 97-148
    • Labrie, F.1
  • 49
    • 45849111454 scopus 로고    scopus 로고
    • Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
    • DOI 10.1016/j.fertnstert.2007.05.057, PII S0015028207012290
    • Schover LR. Androgen therapy for loss of desire in women: Is the benefit worth the breast cancer risk? Fertil Steril 2008;90:129-40 (Pubitemid 351888358)
    • (2008) Fertility and Sterility , vol.90 , Issue.1 , pp. 129-140
    • Schover, L.R.1
  • 50
    • 34047270712 scopus 로고    scopus 로고
    • Associations between testosterone secretion and sexual activity in women
    • DOI 10.1016/j.yhbeh.2007.01.003, PII S0018506X07000049
    • van Anders SM, Hamilton LD, Schmidt N, Watson NV. Associations between testosterone secretion and sexual activity in women. Horm Behav 2007;51:477-82 (Pubitemid 46550424)
    • (2007) Hormones and Behavior , vol.51 , Issue.4 , pp. 477-482
    • Van Anders, S.M.1    Hamilton, L.D.2    Schmidt, N.3    Watson, N.V.4
  • 51
    • 15744384106 scopus 로고    scopus 로고
    • Waist-to-hip ratio is positively associated with bioavailable testosterone but negatively associated with sexual desire in healthy premenopausal women
    • DOI 10.1097/01.psy.0000151747.22904.d7
    • van Anders SM, Hampson E. Waist-to-hip ratio is positively associated with bioavailable testosterone but negatively associated with sexual desire in healthy premenopausal women. Psychosom Med 2005;67:246-50 (Pubitemid 40410960)
    • (2005) Psychosomatic Medicine , vol.67 , Issue.2 , pp. 246-250
    • Van Anders, S.M.1    Hampson, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.